PAGANO, Livio, Oliver A. CORNELY, Alessandro BUSCA, Morena CAIRA, Simone CESARO, Cristiana GASBARRINO, Corrado GIRMENIA, Werner J. HEINZ, Raoul HERBRECHT, Cornelia LASS-FLÖRL, Annamaria NOSARI, Leonardo POTENZA, Zdeněk RÁČIL, Volker RICKERTS, Donald C. SHEPPARD, Arne SIMON, Andrew J. ULLMAN, Caterina Giovanna VALENTINI, Jörg Janne VEHRESCHILD, Anna CANDONI and Maria J.G.T. VEHRESCHILD. Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries. Haematologica. Pavia, ITALY: Ferrata Storti Foundation, 2013, vol. 98, No 10, p. "e127"-"e130", 4 pp. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2012.083063.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
Authors PAGANO, Livio (380 Italy), Oliver A. CORNELY (276 Germany), Alessandro BUSCA (380 Italy), Morena CAIRA (380 Italy), Simone CESARO (380 Italy), Cristiana GASBARRINO (380 Italy), Corrado GIRMENIA (380 Italy), Werner J. HEINZ (276 Germany), Raoul HERBRECHT (250 France), Cornelia LASS-FLÖRL (40 Austria), Annamaria NOSARI (380 Italy), Leonardo POTENZA (380 Italy), Zdeněk RÁČIL (203 Czech Republic, guarantor, belonging to the institution), Volker RICKERTS (276 Germany), Donald C. SHEPPARD (124 Canada), Arne SIMON (276 Germany), Andrew J. ULLMAN (276 Germany), Caterina Giovanna VALENTINI (380 Italy), Jörg Janne VEHRESCHILD (276 Germany), Anna CANDONI (380 Italy) and Maria J.G.T. VEHRESCHILD (276 Germany).
Edition Haematologica, Pavia, ITALY, Ferrata Storti Foundation, 2013, 0390-6078.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.868
RIV identification code RIV/00216224:14740/13:00069044
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.3324/haematol.2012.083063
UT WoS 000328543400002
Keywords in English posaconazole; lipid fomulations of amphotericin B; Mucormycosis; combination therapy; invasive fungal infections; hematological malignancies
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 28/4/2014 16:01.
Abstract
Our case series may have been subject to selection bias, as only those patients who survived long enough to receive a combination therapy were included. However, since interventional trials on this question are unlikely to be performed any time soon, data from registries remain the only available source of structured information on the treatment of mucormycosis. In conclusion, our analysis suggests that a combined antifungal treatment with Lip-AmB+POS may be considered in patients with very aggressive forms of IM.
PrintDisplayed: 22/8/2024 23:34